Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva sees $2.4b from respiratory operations by 2015
Teva sees $2.4b from respiratory operations by 2015
Teva sees $2.4b from respiratory operations by 2015
Submitted by
admin
on November 7, 2010 - 11:54am
Source:
Globes, Israel
News Tags:
Teva Pharmaceuticals
Ventolin HFA
ProAir HFA
QNAZE
allergic rhinitis
Flonase
QVAR
Headline:
Teva sees $2.4b from respiratory operations by 2015
Do Not Allow Advertisers to Use My Personal information
